Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zonguldak Bulent Ecevit University
This study aims to investigate the impact of medications containing the active ingredients hydroxychloroquine and favipiravir on the auditory system, as well as to examine the effect of COVID-19 on hearing and its potential relationship with medication use and COVID-19 vaccine dose.
Age
18–35
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age between 18 and 35 For the Medication group: Having had COVID-19 and using COVID-19 medications For the Non-Medication group: Having had COVID-19 and not using COVID-19 medications For the Control group: Having never had COVID-19
You may not be if
Previously diagnosed with hearing loss Use of ototoxic medications other than those specified Pathology detected during tympanometric evaluation or otoscopic examination Chronic disease Family history of hearing loss History of meningitis Neurological disorders Acute or chronic ear infection Admission to intensive care
Clareo Health | Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
